July 23, 2019

Boustead Securities, LLC, IPO client Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a new and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), an...

July 19, 2019

Boustead Securities, LLC client Aerkomm Inc. (OTCQX: AKOM; Euronext Paris: AKOM), a development stage service provider of in-flight entertainment and connectivity solutions for the airline industry, announced that the French Autorité des Marchés Financiers (AMF) has gr...

July 11, 2019

Boustead Securities client Blackboxstocks Inc. (OTC PINK: BLBX) (“Blackbox”), a developer of real-time web and mobile based analytical software tools for stock and options traders, today announced that it has entered into an exclusive advisory agreement with Boustead S...

July 9, 2019

PetCure Oncology, a company providing veterinary cancer treatment utilizing noninvasive stereotactic radiosurgery (SRS) and stereotactic radiation therapy (SRT), announced it has engaged Boustead Securities, LLC for a Regulation D 506(C) offering and other capital mark...

July 1, 2019

A new type of cancer treatment, immunotherapy, might turn the tables in the battle between cancer and the immune system. Immunotherapy may either stimulate the immune system globally or cause the immune system to attack cancer directly. There are several types of immun...

Please reload

Recent Posts
  • Boustead Securities LinkedIn
  • Facebook Basic Square
Please reload

Archive
Please reload

Search By Tags